P
ediatric obesity continues at unacceptably high levels, with significant impact on child health and wellbeing (1, 2) . In hospitalized children, obesity has been associated with increased mortality (3, 4) , increased hospital length of stay (LOS) (3) , and increased frequency of adverse patient safety events (5) . In both adult and pediatric critically ill patients, obesity may be associated with increased risk of death, although this varies between studies (4, 6-8). There may be physiologic differences and increased cardiometabolic risk for patients with the most severe forms of obesity (9) (10) (11) .
Vascular access is a crucial component of care in critically ill patients, allowing the delivery of medications, fluids, parenteral nutrition, and blood products. Access may be more difficult to obtain in patients with obesity due to anatomic considerations, but data are limited to predominantly single-center studies with small sample sizes and inconsistent definitions of obesity (12, 13) . In addition, central venous access predisposes patients to a wide variety of complications (14) . Obesity may independently increase the risk of some of these complications, such as thrombosis (15, 16) and infection (3) .
The goal of this study is to investigate associations between obesity, including severe obesity, and vascular access procedures and complications in a national sample of critically ill pediatric patients. Our hypothesis is that patients with obesity will require more vascular access procedures than their normal weight counterparts and will experience more related complications.
MATERIALS AND METHODS
This was a retrospective cohort study of deidentified patient data collected from January 1, 2009, to December 31, 2014, within the Virtual Pediatric Systems (VPS), LLC database. The database includes specified data elements that are prospectively collected by member PICUs across the United States. Data were provided by VPS. No endorsement or editorial restriction of the interpretation of these data or opinions of the authors has been implied or stated. This study was determined to qualify for exemption by the Wake Forest School of Medicine institutional review board.
Cohort Identification
Patients admitted to member PICUs age 2 to less than 18 years were evaluated for inclusion in the analysis. Patients under 2 years old were excluded, as overweight and obesity are not consistently defined for this age group in the United States. Underweight patients were excluded due to a high likelihood of comorbid pathology which would confound the analysis. For patients with multiple admissions, only the first admission was considered. Our primary analysis was a complete case analysis, in which we excluded all patients with missing or physiologically implausible height or weight. All other patients were included (Fig. 1) . As a secondary analysis, we used multiple imputation to estimate heights and weights for missing or implausible values in order to include all available subjects. Weight-for-age has previously been shown to be inferior to BMI-for-age in assessing obesity-related risks within the VPS database, which informed this strategy (4). Since few weights were missing and no sex or age values were missing, we first used Markov Chain Monte Carlo to impute enough weight values to make the missingness pattern monotone, followed by regression imputation for the missing heights.
Data elements obtained from VPS included patient demographics; clinical characteristics including diagnoses and severity of illness by Pediatric Index of Mortality (PIM) 2 score; weight; height when available; PICU admission, discharge, and LOS; outcome and disposition; and type and duration of vascular access. Primary diagnoses were designated within the database and were categorized into respiratory, trauma/toxicology, neurology, cardiology, endocrine, infectious disease, and other. Patients with a complex chronic condition (CCC) were identified using the Pediatric Medical Complexity Algorithm version 2.0 using the less conservative algorithm, as recommended for use with hospital discharge data by the algorithm developers (17, 18) . PIM-2 was chosen as the measure of illness severity because it is a mandatory data element in VPS. Risk of mortality by PIM-2 was evaluated as a continuous variable. Age was categorized into 2-5, 6-12, and 13-18 years.
The primary exposure was body mass index (BMI) category, calculated according to commonly used guidelines, including the Center for Disease Control (2, (19) (20) (21) from age, sex, height, and weight. Outliers (height-and weight-for-age z scores < -5 or > 5) were excluded from the analysis. BMI percentile was used to classify subjects as follows: 5% to less than 85% normal weight, 85% to less than 95% overweight, 100% to less than 120% of 95% class 1 obesity, 120% to less than 140% of 95% class 2 obesity, and greater than or equal to 140% of 95% class 3 obesity.
Outcome Measures
The primary outcome was placement of any vascular device. Vascular devices were categorized as arterial catheters, percutaneous central venous catheters (CVCs), peripherally inserted central catheters (PICCs), portacaths, Broviac/Hickman catheters, and hemodialysis catheters. Peripheral IV catheters (PIVs) are not recorded in the VPS database and were not included. The clinical indication for arterial catheters, hemodialysis catheters, and portacaths often may be diagnosis specific and different from the indications for the other devices studied. Therefore, as a secondary analysis, we evaluated placement of any venous rescue device (percutaneous CVC, PICC, and Broviac) as an outcome and placement of percutaneous CVCs and PICCs individually as outcomes. For devices with documented times of placement and removal, we determined device time in the PICU.
Complications are not a required field; however, centers that committed to reporting these data do so consistently. Complications with vascular access were organized into categories as follows: mechanical (broken device, displaced/ dislodged, not working not otherwise specified, obstructed), infection (device-related blood stream infection, nonsurgical site infections, surgical site infection-deep, surgical site infection-superficial), thrombosis (clotted/thrombosed), bleeding (bleeding requiring reoperation, bleeding not requiring reoperation), and other (brain herniation, bronchopleural fistula, cardiorespiratory arrest, death, dysrhythmia, hemothorax, hypotension, new onset seizure, other, paresis/paralysis, pleural effusion requiring drainage, pneumothorax, reoperation during admission [unplanned] ). 
Analysis
Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC). Descriptive statistics of admission characteristics were compared by BMI category using Pearson chisquare analysis for categorical variables and analysis of variance for continuous variables. Univariate analyses were performed to identify factors associated with our outcomes, including BMI category, age, sex, primary diagnosis, presence of a CCC, severity of illness score (PIM-2), and trauma or postoperative status. Factors found to be significantly associated with device placement in the univariate analysis were included in a mixedeffects multivariable logistic regression model which treated hospital as a random effect. Each admission was only represented once in the clinical and demographic information and in the logistic regression modeling. Wilcoxon rank-sum tests were used to assess the association between BMI category and times (LOS and device time in the PICU). A p value of less than 0.05 was used to define statistical significance.
RESULTS
We identified 120,272 unique patient admissions meeting all inclusion criteria to 94 PICUs within the United States (Fig. 1 ). These patients were 63.2% normal weight, 15.7% overweight, 13.7% class 1 obesity, 4.6% class 2 obesity, and 3.0% class 3 obesity, with other demographics displayed by BMI category in Table 1 . Patients with obesity were more likely to be older, male, and Black or Hispanic (p < 0.001). Subjects with class 1 and class 2, but not class 3 obesity, were more likely to have a nonsurgical (p < 0.001) PICU admission. Class 3 obesity was positively associated with presence of a CCC (p < 0.001). There was no clear trend in severity of illness by weight category, although PICU LOS was longer for patients with all classes of obesity (p < 0.001).
A total of 73,964 devices were placed in 45,409 patients (37.8% of the total cohort received a vascular device). Arterial catheters and percutaneous CVCs were the most common devices placed, accounting for 50.2% and 27.3% of the total number of devices, respectively. Overall, 29% of patients had arterial catheters and 16% had percutaneous CVCs. Most device types differed significantly by weight status, with the exception of Broviac catheters, as shown in Table 2 . The percentage of patients who underwent placement of any vascular access device (p < 0.001) or any CVC (p < 0.001) decreased with increasing BMI category. Patients with obesity were less likely to have devices present at admission (p < 0.001) and more likely to have them at discharge from the PICU (p = 0.005). PICC lines were more likely to be present at discharge from the PICU (6.4% of patients) than other types of catheter.
One hundred of 142 centers (70%) reported complications with vascular access devices, including a total of 32,052 patients with devices placed. A total of 1,427 complications were reported, as shown in Table 3 , with the highest prevalence in patients with class 3 obesity (6.4% vs 4.0% in normal weight patients; p < 0.001). Mechanical (p < 0.001), bleeding (p = 0.011), and other (p = 0.002) complications were more common in patients with obesity.
Device details for percutaneous CVCs and PICC lines are shown in Table 4 . We found similar trends for decreasing likelihood of device placement prior to admission with increasing BMI category for both types of devices. Although percutaneous CVCs were more likely to remain present at PICU discharge for patients with obesity (p = 0.005), no association was seen for PICC lines. Both types of devices were present for a longer amount of time in the PICU when placed in patients with obesity (CVC p < 0.001, PICC p = 0.021), but device time as a percent of LOS was not associated with BMI category. The prevalence of complications per device increased with patient obesity, as seen previously (CVC p = 0.039, PICC p = 0.011).
Mixed-effects multivariable logistic regression was used to assess the effect of BMI on catheter placements and complications, adjusted for patient covariates and for the hospital in which the patient received treatment. Subjects with class 3 obesity were significantly less likely (odds ratio [OR], 0.74; 95% CI, 0.67-0.81) to undergo placement of any device compared with normal weight patients, as shown in Figure 2 and Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/PCC/A549). We had similar findings for placement of a percutaneous CVC, with an OR of 0.85 (95% CI, 0.75-0.97) for class 3 obesity. In contrast, patients with all classes of obesity were more likely to undergo placement of a PICC line, with the strongest association in those with class 2 obesity (OR, 1.26, 95% CI, 1.14-1.40). Both class 1 and class 3 obesity were independent risk factors for developing a complication, with an OR of 1.31 (95% CI, 1.11-1.53) and 1.45 (95% CI, 1.07-1.99), respectively. These findings persisted when multiple imputation was used to incorporate data from subjects with missing or implausible height and weight values (Supplemental Table 1 
DISCUSSION
To our knowledge, this is the first study to assess the requirement for vascular access in a critically ill pediatric population by BMI status. We found that patients with severe obesity were less likely to undergo placement of a vascular access device but that, once placed, those devices were more likely to be present at discharge from the PICU. This may reflect clinician concerns about obtaining and maintaining access in these patients or could represent different diagnoses or stages of illness at the time of discharge. We had hypothesized that more devices would be needed for patients with overweight or obesity due to anatomic difficulties establishing access prohibiting the use of PIVs. Data regarding PIV placement are not available in the VPS database, and thus could not be directly investigated in this study. The placement of fewer devices in children with obesity, especially percutaneous CVCs, could still reflect anatomic difficulties, as device placement attempts which were ultimately unsuccessful may not be captured.
Children with obesity have a longer device time in the PICU and are more likely to leave the PICU with a vascular access device. The incidence of complications increases with prolonged use of a CVC (22) , so prompt removal is important in preventing adverse events. A greater percentage of PICC lines and Broviacs, which are intended for longer use, were present at discharge from the PICU in this cohort.
Patients with obesity were more likely to experience complications related to their vascular access device. Of note, the 4.5% prevalence of complications in this cohort is lower than that previously reported in the literature (14) . Mechanical and bleeding complications had the strongest association with obesity in our study. One prospective observational study in Thailand previously identified an association between mechanical complications during CVC insertion and pediatric obesity, but they used BMI greater than 30 kg/m 2 as the definition of obesity without accounting for age or sex, which makes these results difficult to interpret (12) . In contrast, a single-center prospective study from Brazil reported that lower body weight was associated with an increased risk of failure at the first insertion site. This study did not collect height to allow calculation of BMI (13). Our results, based on BMI category determined from age, sex, height, and weight, suggest that anatomic and/or physiologic differences in patients with severe obesity appear to result in increased risk of mechanical and bleeding complications.
We found no associations with BMI category for thrombosis or infection, in contrast to prior studies (15, 16, 23, 24) . The low numbers of reported complications, even in this large database, limits this analysis. Of note, these data only include complications that occurred while the patient was in the PICU. The overall incidence of complications was higher for children with obesity, which may have been influenced by the longer device time in PICU for children with obesity. Children with obesity were also more likely to be discharged from the PICU with their device in place, increasing the risk of further complications during the remainder of their hospital stay. Future studies could investigate obesity as a risk factor for vascular access device complications in more detail. A strength of this study is the use of the large VPS database, a prospective observational cohort of consecutive PICU admissions from hospitals across the United States. VPS data undergo extensive quality validation, with inter-rater reliability concordance consistently above 95% (25) . Notably, the prevalence of obesity in this cohort (21%) is higher than the national average of 17%. This may be related to the older age of our cohort compared with U.S. census data (26) and the higher prevalence of obesity at older ages (1, 27) . The relative rates of hospitalization and requirement for critical care between patients of different weight classes are unknown.
For the complete case analysis described above, we only included patients with a measured and physiologically plausible height and weight. This excluded nearly 50% of admissions in the database. Although a moderate correlation was noted between weight-for-age z score and BMI z score, Ross et al (4) have previously demonstrated that using weight-for age z score as the exposure falsely implied a protective effect of mild obesity on patient mortality within the VPS database. Therefore, we repeated our primary analysis using multiple imputation for missing height data. Although there are small differences in the ORs obtained, none represent a clinically significant change from the results obtained with recorded heights and weights ( Fig. 2; and Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/PCC/A549). There are several limitations to this study. A major limitation is the large proportion of missing height data, as described above; however, the multiple imputation analysis supported our original findings. The need for vascular access device placement can be influenced by the relative success of PIV placement, and data on PIVs were not available in the VPS database. Especially in patients with obesity, successful placement of PIVs and other vascular access devices may depend on provider skill and use of ultrasound (28) , none of which are captured in this database. The relative use of different type of devices may vary over time within a given institution, which was not assessed in our analysis. As previously stated, device complications were not the required element in this database, which may bias our results based on the characteristics of centers that did report these findings. Centers that did report complications did so systematically. We have limited information on the medical decision-making around device placement and removal in this study; prospective studies on attempted and successful device placement are needed to understand these findings in greater detail. The database only includes subject information during PICU admission, so data on device removal, further complications, and effects on the remainder of the hospital stay are not available. Detailed retrospective chart review at individual sites or a prospective study may be helpful in identifying potential interventions to decrease vascular access complications for patients with obesity. Future study could investigate whether issues with vascular access contribute to PICU outcomes for children with obesity.
CONCLUSIONS
Overall, our study of a large database of U.S. PICUs found that severe obesity was associated with decreased likelihood of placement of a vascular access device but increased likelihood of device-related complications. Future prospective studies could better assess the associations of vascular access with patient outcomes and the incidence and, ultimately, prevention of complications associated with these devices to improve clinical outcomes in critically ill children with obesity.
